Breast Cancer Mortality Hot Spots Among Black Women With de Novo Metastatic Breast Cancer

被引:2
|
作者
Han, Yunan [1 ,2 ]
Langston, Marvin [3 ]
Fuzzell, Lindsay [4 ]
Khan, Saira [5 ]
Lewis-Thames, Marquita W. [6 ]
Colditz, Graham A. [1 ,7 ,8 ]
Moore, Justin Xavier [9 ]
机构
[1] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA
[2] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang, Peoples R China
[3] Kaiser Permanente, Northern Calif, Div Res, Oakland, CA USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA
[5] Univ Delaware, Coll Hlth Sci, Epidemiol Program, Newark, DE USA
[6] Northwestern Univ, Ctr Community Hlth, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA
[7] Barnes Jewish Hosp, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA
[8] Washington Univ, Sch Med, St Louis, MO USA
[9] Augusta Univ, Dept Populat Hlth Sci, Div Epidemiol, Augusta, GA USA
基金
美国国家卫生研究院;
关键词
RACIAL RESIDENTIAL SEGREGATION; AFRICAN-AMERICAN; STAGE IV; INCIDENCE RATES; WHITE WOMEN; DISPARITIES; SURVIVAL; TUMOR; OUTCOMES; IMPACT;
D O I
10.1093/jncics/pkaa086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Black women living in southern states have the highest breast cancer mortality rate in the United States. The prognosis of de novo metastatic breast cancer is poor. Given these mortality rates, we are the first to link nationally representative data on breast cancer mortality hot spots (counties with high breast cancer mortality rates) with cancer mortality data in the United States and investigate the association of geographic breast cancer mortality hot spots with de novo metastatic breast cancer mortality among Black women. Methods: We identified 7292 Black women diagnosed with de novo metastatic breast cancer in Surveillance, Epidemiology, and End Results (SEER). The county-level characteristics were obtained from 2014 County Health Rankings and linked to SEER. We used Cox proportional hazards models to calculate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for mortality between hot spot and non-hot spot counties. Results: Among 7292 patients, 393 (5.4%) resided in breast cancer mortality hot spots. Women residing in hot spots had similar risks of breast cancer-specific mortality (aHR = 0.99, 95% CI = 0.85 to 1.15) and all-cause mortality (aHR = 0.97, 95% CI = 0.84 to 1.11) as women in non-hot spots after adjusting for individual and tumor-level factors and treatments. Additional adjustment for county-level characteristics did not impact mortality. Conclusion: Living in a breast cancer mortality hot spot was not associated with de novo metastatic breast cancer mortality among Black women. Future research should begin to examine variation in both individual and population-level determinants, as well as in molecular and genetic determinants that underlie the aggressive nature of de novo metastatic breast cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Breast surgery in de novo metastatic breast cancer
    Chan, P.
    Kuah, S.
    Lu, S.
    Goh, M. H.
    Chen, J.
    Tan, E. Y.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S79 - S79
  • [2] Epidemiology of De Novo Metastatic Breast Cancer
    Daily, Karen
    Douglas, Emily
    Romitti, Paul A.
    Thomas, Alexandra
    CLINICAL BREAST CANCER, 2021, 21 (04) : 302 - 308
  • [3] Survival in Young Women with De Novo or Recurrent Metastatic Breast Cancer
    Varella, Leticia
    Zheng, Yue
    Rosenberg, Shoshana
    Kirkner, Gregory
    Snow, Craig
    Ruddy, Kathryn
    Tamimi, Rulla
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia
    Come, Steven
    Collins, Laura
    Warner, Ellen
    Dibble, Kate
    Winer, Eric
    Partridge, Ann
    CANCER RESEARCH, 2024, 84 (09)
  • [4] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    D J A Lobbezoo
    R J W van Kampen
    A C Voogd
    M W Dercksen
    F van den Berkmortel
    T J Smilde
    A J van de Wouw
    F P J Peters
    J M G H van Riel
    N A J B Peters
    M de Boer
    P G M Peer
    V C G Tjan-Heijnen
    British Journal of Cancer, 2015, 112 : 1445 - 1451
  • [5] Prognosis of metastatic breast cancer: Differences between patients with de novo and recurrent metastatic breast cancer
    Tjan-Heijnen, V. C. G.
    Lobbezoo, D. J. A.
    van Kampen, R. J. W.
    Dercksen, M. W.
    Voogd, A. C.
    van den Berkmortel, F.
    Smilde, T. J.
    van de Wouw, A. J.
    van Riels, J. M. G. H.
    Peters, N. A. J. B.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S72 - S73
  • [6] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo, D. J. A.
    van Kampen, R. J. W.
    Voogd, A. C.
    Dercksen, M. W.
    van den Berkmortel, F.
    Smilde, T. J.
    van de Wouw, A. J.
    Peters, F. P. J.
    van Riel, J. M. G. H.
    Peters, N. A. J. B.
    de Boer, M.
    Peer, P. G. M.
    Tjan-Heijnen, V. C. G.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1445 - 1451
  • [7] Surgical Treatment of de novo Metastatic Breast Cancer
    Marguerite M. Rooney
    Krislyn N. Miller
    Laura H. Rosenberger
    Jennifer K. Plichta
    Current Breast Cancer Reports, 2022, 14 : 83 - 92
  • [8] Surgical Treatment of de novo Metastatic Breast Cancer
    Rooney, Marguerite M.
    Miller, Krislyn N.
    Rosenberger, Laura H.
    Plichta, Jennifer K.
    CURRENT BREAST CANCER REPORTS, 2022, 14 (03) : 83 - 92
  • [9] Genomic Characterization of De Novo Metastatic Breast Cancer
    Mullangi, Samyukta
    Vasan, Neil
    CLINICAL BREAST CANCER, 2022, 22 (02) : 98 - 102
  • [10] Genomic Characterization of de novo Metastatic Breast Cancer
    Garrido-Castro, Ana C.
    Spurr, Liam F.
    Hughes, Melissa E.
    Li, Yvonne Y.
    Cherniack, Andrew D.
    Kumari, Priti
    Lloyd, Maxwell R.
    Bychkovsky, Brittany
    Barroso-Sousa, Romualdo
    Di Lascio, Simona
    Jain, Esha
    Files, Janet
    Mohammed-Abreu, Ayesha
    Krevalin, Max
    MacKichan, Colin
    Barry, William T.
    Guo, Hao
    Xia, Daniel
    Cerami, Ethan
    Rollins, Barrett J.
    MacConaill, Laura E.
    Lindeman, Neal, I
    Krop, Ian E.
    Johnson, Bruce E.
    Wagle, Nikhil
    Winer, Eric P.
    Dillon, Deborah A.
    Lin, Nancy U.
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1105 - 1118